Previously, we showed that a chemokine receptor-defined CD4+ T-cell subset termed T helper 17.1 (Th17.1; CCR6+CXCR3+CCR4-/dim) is associated with early MS activity (11). This evidence concerns the gene CD4 and myeloid sarcoma.